Clinical Trial Details
— Status: Completed
Administrative data
NCT number |
NCT03512093 |
Other study ID # |
HCR17005 |
Secondary ID |
|
Status |
Completed |
Phase |
|
First received |
|
Last updated |
|
Start date |
May 1, 2018 |
Est. completion date |
March 31, 2021 |
Study information
Verified date |
January 2023 |
Source |
University of Oxford |
Contact |
n/a |
Is FDA regulated |
No |
Health authority |
|
Study type |
Observational
|
Clinical Trial Summary
Since 2008, preterm neonates are taking care of in a Special Baby Care Unit (SCBU). Those
born less than 34 weeks of gestation are followed-up monthly for one year for monitoring
their hematocrit level, growth and development.
Medical chart reviews are useful to evaluate the burden of diseases, characterize care
treatment patterns and clinical outcomes by patients' subgroups; ultimately it can help
identifying gaps in care pathways thus improving quality of care and ultimately reducing
mortality. Medical records of all preterm neonates hospitalized in the SCBU including those
followed up during their first year of life are computerized.
The investigators propose to review the clinical charts of the preterm neonates in regards to
four main points of care a) feeding, b) infections including early onset of neonatal sepsis,
necrotizing enterocolitis and umbilical cord infection, c) body temperature control and d)
respiratory distress.
This medical charts review will be complemented by i) focus group discussions (FGD) with the
medical staff working in the SCBU on the benefits and difficulties in using the existing
guidelines for preterm care and by ii) interviews with mothers who delivered a preterm
neonate on their experience in caring for their child and the challenges they faced.
While performing the retrospective part of the project and after discussing the preliminary
findings from the medical staff perception of the existing guidelines, the investigators will
evaluate the feasibility to implement some additional recommendations to improve preterm
birth outcomes based on recent literature and new protocols for resource-limited settings.
Description:
This study aims to describe the neonatal clinical outcome of preterm neonates (< 37+0 weeks
of gestation) in terms of mortality and prematurity-related morbidity and the growth and
neurodevelopment of preterm neonates (< 34+0 weeks of gestation) in the first year of life in
order to optimize service delivery for preterm neonates in a resource-constraint setting. The
study will consist of 3 parts as follows:
Part A: A retrospective chart review of preterm neonates born in one of the birthing SMRU
unit between January 2008 and December 2017 and for whom a medical chart is available. In
addition we propose to analyze the growth trajectory, the prevalence of anemia (Hct < 33%)
and the level of neurodevelopment achieved in the first year of life reported in the clinical
charts of preterm neonates born < 34+0 weeks of gestation.
Part B: Focus Group Discussion (FGD) of the medical staff working in the SCBU firstly on the
benefits and difficulties in using existing guidelines for preterm care and secondly on the
feasibility and acceptability of the revised guidelines 3-6 months after their
implementation.
Part C: Interviews of mothers who delivered preterm neonates (< 37+0 weeks of gestation) to
understand the challenges they faced while caring for their child.
This study was funded by Shoklo Malaria Research Unit Core funding (Wellcome Trust). Grant
reference number is 220211.
Summary of Results:
Preterm birth is a major public health concern worldwide with the largest burden of morbidity
and mortality falling upon the low- and middle-income countries. Evidence-based interventions
for preterm neonatal care exist but often meet with barriers to implementation based on
constraints in resource-poor settings.
This study summarizes clinical outcomes among preterm neonates born to mothers attending
antenatal care at SMRU, regarding four main points of care: feeding, infections, thermal
care, and respiratory care. In addition to these clinical outcomes, mixed methods were
employed to highlight key implementation outcomes for SCBU care provision in this setting.
Between January 1, 2008, and December 31, 2017, a total of 2319 preterm births were
documented, of which, 203 stillbirths were excluded from further analysis. There were 237
deaths documented over the study period, with the proportion of deaths decreasing
significantly from 14.4% (144/999) during the early establishment period of SCBU (2008-2011)
to 11.0% (66/603) during the expansion of SCBU care to all sites (2012-2014) and to 5.3%
(27/514) while the continuum of care was performed more routinely at all sites (2015-2017)
(p<0.001). Mortality reduction was observed in all categories of prematurity, with the
largest reduction (68%) observed among very preterm neonates (EGA 28-32 weeks). Most deaths
(184/237, 77.6%) occurred in the early neonatal period, of which half were within hours of
birth (93/184).
Admission for surveillance and further care was routine. Very preterm neonates (EGA 28-32
weeks) remained under observation for nearly three weeks longer than moderate preterm
neonates (EGA 33-36 weeks) with a median of 34 days (IQR 20, 49 days) compared to a median of
9 days (IQR 4, 14). Hypothermia (temperature < 36.5ºC) was the most common cause of abnormal
body temperature on admission (402/480, 83.8%) independent of prematurity. Nearly one-third
of neonates (394/1215, 32.4%) received intravenous antibiotics on admission to SCBU. Duration
of oxygen therapy was longer for very preterm (median of 18 days [IQR 10, 32]) compared to
moderate preterm neonates (2.5 days [IQR 2-6.5]).
Mothers of neonates (n=9) explained acceptability, satisfaction, and coverage outcomes
related to SCBU care. Despite difficult circumstances around access and financial issues,
many women realized the need for SCBU care for their newborns. The patient-centered care
offset risks associated with both seeking care and the substantial toll that extended
hospital stays took on women's personal lives. FGDs with medical staff (n=27) helped explain
feasibility, fidelity, and effectiveness outcomes.
Conclusions:
SMRU provides a package of routine and specialized services for antenatal, intrapartum,
delivery, postpartum, and newborn care that is facility-based. The package of care for
preterm birth and small and sick newborns has evolved over the years and now includes the
administration of steroids to women with preterm labor between 27-34 weeks of gestation,
maternal antibiotic prophylaxis in case of prolonged rupture of membranes, and diagnosis and
treatment of maternal infections The Special Baby Care Units for specialized care of preterm,
small, or sick neonates has been equipped with equipment for optimizing respiratory support,
phototherapy, feeding, and thermoregulation. The on-site medical staff has been trained in
newborn resuscitation and participates in routine exercises based on the Basic Emergency
Obstetric & Newborn Care Life Support curriculum. And all these efforts have resulted in a
reduction in mortality among all categories of neonates, mostly those very preterms (EGA
28-32 weeks).
However, despite this improvement in survival, interviews and FGDs findings highlighted the
barriers in this resource-limited setting and their impact on the feasibility, fidelity, and
effectiveness of evidence-based SCBU care. Financial burdens and social issues related to
home life were often a pull away from the hospital, hampering the acceptability,
appropriateness, and satisfaction mothers felt in accessing clinics or being admitted to the
SCBU facility for long periods of time. Medical staff often adapted interventions to fit the
financial and environmental constraints imposed by this setting. To further reduce neonatal
mortality in preterm neonates there is an urgent need to consider the financial and social
constraints on the mothers as well as support to the medical staff that goes beyond improving
knowledge.
The final enrolment numbers: Part A: 2116 charts of preterm neonates born to mothers
attending ANC at SMRU retrospectively analyzed; 27 participants to FGD and 9 interviews.